167 related articles for article (PubMed ID: 10384136)
1. Deficiency of 5-lipoxygenase abolishes sex-related survival differences in MRL-lpr/lpr mice.
Goulet JL; Griffiths RC; Ruiz P; Spurney RF; Pisetsky DS; Koller BH; Coffman TM
J Immunol; 1999 Jul; 163(1):359-66. PubMed ID: 10384136
[TBL] [Abstract][Full Text] [Related]
2. Morphological analysis of autoimmune disease in MRL-lpr,Yaa male mice with rapidly progressive systemic lupus erythematosus.
Suzuka H; Yoshifusa H; Nakamura Y; Miyawaki S; Shibata Y
Autoimmunity; 1993; 14(4):275-82. PubMed ID: 8347770
[TBL] [Abstract][Full Text] [Related]
3. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K
Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501
[TBL] [Abstract][Full Text] [Related]
4. Severe tissue trauma triggers the autoimmune state systemic lupus erythematosus in the MRL/++ lupus-prone mouse.
Anam K; Amare M; Naik S; Szabo KA; Davis TA
Lupus; 2009 Apr; 18(4):318-31. PubMed ID: 19276300
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice.
Hoi AY; Hickey MJ; Hall P; Yamana J; O'Sullivan KM; Santos LL; James WG; Kitching AR; Morand EF
J Immunol; 2006 Oct; 177(8):5687-96. PubMed ID: 17015758
[TBL] [Abstract][Full Text] [Related]
6. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
[TBL] [Abstract][Full Text] [Related]
7. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies.
Liang B; Gee RJ; Kashgarian MJ; Sharpe AH; Mamula MJ
J Immunol; 1999 Aug; 163(4):2322-9. PubMed ID: 10438978
[TBL] [Abstract][Full Text] [Related]
8. Role of MHC-linked genes in autoantigen selection and renal disease in a murine model of systemic lupus erythematosus.
Sekine H; Graham KL; Zhao S; Elliott MK; Ruiz P; Utz PJ; Gilkeson GS
J Immunol; 2006 Nov; 177(10):7423-34. PubMed ID: 17082662
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of the Ets family transcription factor Fli-1 markedly prolongs survival and significantly reduces renal disease in MRL/lpr mice.
Zhang XK; Gallant S; Molano I; Moussa OM; Ruiz P; Spyropoulos DD; Watson DK; Gilkeson G
J Immunol; 2004 Nov; 173(10):6481-9. PubMed ID: 15528390
[TBL] [Abstract][Full Text] [Related]
10. Interferon regulatory factor-5 deficiency ameliorates disease severity in the MRL/lpr mouse model of lupus in the absence of a mutation in DOCK2.
Yasuda K; Watkins AA; Kochar GS; Wilson GE; Laskow B; Richez C; Bonegio RG; Rifkin IR
PLoS One; 2014; 9(7):e103478. PubMed ID: 25076492
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
[TBL] [Abstract][Full Text] [Related]
12. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.
Goury A; Meghraoui-Kheddar A; Belmokhtar K; Vuiblet V; Ortillon J; Jaisson S; Devy J; Le Naour R; Tabary T; Cohen JH; Schmidt AM; Rieu P; Touré F
J Immunol; 2015 Apr; 194(8):3612-22. PubMed ID: 25762779
[TBL] [Abstract][Full Text] [Related]
13. Expression of heterozygous lpr gene in MRL mice. II. Acceleration of glomerulonephritis, sialadenitis, and autoantibody production.
Carlsten H; Tarkowski A; Jonsson R; Nilsson LA
Scand J Immunol; 1990 Jul; 32(1):21-8. PubMed ID: 2382106
[TBL] [Abstract][Full Text] [Related]
14. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
[TBL] [Abstract][Full Text] [Related]
15. Lpr and MRL background gene involvement in the control of adjuvant enhanced arthritis in MRL-lpr mice.
Ratkay LG; Tait B; Tonzetich J; Waterfield JD
J Autoimmun; 1994 Oct; 7(5):561-73. PubMed ID: 7530961
[TBL] [Abstract][Full Text] [Related]
16. The characteristics of hematopoietic stem cells from autoimmune-prone mice and the role of neural cell adhesion molecules in abnormal proliferation of these cells in MRL/lpr mice.
Wang X; Hisha H; Cui W; Song C; Mizokami T; Okazaki S; Li Q; Feng W; Kato J; Jiang S; Fan H; Ikehara S
Haematologica; 2007 Mar; 92(3):300-7. PubMed ID: 17339178
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of 5-lipoxygenase accelerates renal allograft rejection in mice.
Goulet JL; Griffiths RC; Ruiz P; Mannon RB; Flannery P; Platt JL; Koller BH; Coffman TM
J Immunol; 2001 Dec; 167(11):6631-6. PubMed ID: 11714834
[TBL] [Abstract][Full Text] [Related]
18. Use of genetic knockouts to modulate disease expression in a murine model of lupus, MRL/lpr mice.
Reilly CM; Gilkeson GS
Immunol Res; 2002; 25(2):143-53. PubMed ID: 11999168
[TBL] [Abstract][Full Text] [Related]
19. C1q deficiency and autoimmunity: the effects of genetic background on disease expression.
Mitchell DA; Pickering MC; Warren J; Fossati-Jimack L; Cortes-Hernandez J; Cook HT; Botto M; Walport MJ
J Immunol; 2002 Mar; 168(5):2538-43. PubMed ID: 11859149
[TBL] [Abstract][Full Text] [Related]
20. Effects of complement factor D deficiency on the renal disease of MRL/lpr mice.
Elliott MK; Jarmi T; Ruiz P; Xu Y; Holers VM; Gilkeson GS
Kidney Int; 2004 Jan; 65(1):129-38. PubMed ID: 14675043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]